The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Cidara Therapeutics Common Stock 171757107 6,639 1,508,794 SH   SOLE   1,508,794 0 0
CymaBay Therapeutics Common Stock 23257D103 6,110 551,477 SH   SOLE   551,477 0 0
Dicerna Pharmaceuticals Common Stock 253031108 3,410 223,457 SH   SOLE   223,457 0 0
Egalet Common Stock 28226B104 359 2,889,926 SH   SOLE   2,889,926 0 0
ESSA Pharma Common Stock 29668H708 3,256 1,084,848 SH   SOLE   1,084,848 0 0
FibroGen Common Stock 31572Q808 7,937 130,646 SH   SOLE   130,646 0 0
Jounce Therapeutics Common Stock 481116101 3,445 529,965 SH   SOLE   529,965 0 0
Kezar Life Sciences Common Stock 49372L100 14,843 693,272 SH   SOLE   693,272 0 0
ObsEva Common Stock H5861P103 18,019 999,364 SH   SOLE   999,364 0 0
Paratek Pharmaceuticals Common Stock 699374302 25,224 2,600,410 SH   SOLE   2,600,410 0 0
Pieris Pharmaceuticals Common Stock 720795103 4,358 778,230 SH   SOLE   778,230 0 0
Replimune Common Stock 76029N106 82,166 5,103,455 SH   SOLE   5,103,455 0 0
Sienna Biopharmaceuticals Common Stock 82622H108 11,243 758,610 SH   SOLE   758,610 0 0
Translate Bio Common Stock 89374L104 24,376 2,437,601 SH   SOLE   2,437,601 0 0